Updated treatment recommendations for type 2 diabetes mellitus have been issued by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Revisions to the treatmen
4. The draftalgorithm doesn't actually specify that an SGLT2 inhibitor or GLP-1 agonistshould only be added if the patient doesn't achieve HbA1c targets with metformin and lifestyle(实际上,新指南草案并未刻意强调只有在二甲双胍治疗与生活方式干预后HbA1c不能达标的患者才使用SGLT-2抑制剂或GLP-1...
205–216. 131. effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the step 4 randomized clinical trial. jama 325(14):1414–1425. 132.metabolic ...
perg lycaem ia intype 2diabetes:a consensus algorithm for the init iation and adjus tment of therapy [ J] . D iabeto logia, 2006, 49:1711 - 1721. 6 UK P rospect ive Diabetes study G roup. T ight blood pressure control and
An Analysis of the Work Effort Required for Electronic Prescribing Following the Consensus Algorithm of the ADA and EASD to Medically Manage Hyperglycemia in Type 2 DiabetesJoy, S VRodgers, Pt
Charles F Shaefer.Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for primary care practitioners:four pivotal points. Excerpta Medica Inc . 2008Charles F Shaefer.Implications of the ADA/EASD consensus algorithm for treatment of type 2 diabetes mellitus for ...
(2010) Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia 53 , 1258-1269 /Sten, Madsbad. (2012) Type 2 diabetes: which drug as add-on to metformin?. The Lancet 379 , 2222-2223 /Schernthaner...
The ADA and EASD have recently published a consensus algorithm to guide management of hyperglycemia in adults with type 2 diabetes.This article reviews the guidelines, and restates the recommendations in simple words, while emphasizing the salient points.Kalra...
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Schernthaner G,Barnett A H,Betteridge D J,Carmena R,Ceriello A,Charbonnel B,Hanefeld M,Lehmann R,Malecki M T,Nesto R,Pirags V,Scheen A,Seufert J,Sjoh?
The ADA/EASD-2006 algorithm was adhered to in 33% patients up to study month 3, vs. 17.2% throughout the entire 6-month period.ConclusionIn patients with T2DM seen in primary care, the HbA1c target was met in 48.0% after adjusting their AAs. However, this is not reflected in greater ...